Randomized COMparison of Platelet Inhibition With Abciximab, TiRofiban and Eptifibatide During Percutaneous Coronary Intervention in Acute Coronary Syndromes - Concepedia

Concepedia

Publication | Open Access

Randomized COMparison of Platelet Inhibition With Abciximab, TiRofiban and Eptifibatide During Percutaneous Coronary Intervention in Acute Coronary Syndromes

DOI Full Paper Access

123

Citations

22

References

2002

Year

Wayne Batchelor, Thaddeus R. Tolleson, Yao Huang, Rhonda L. Larsen, R. Michael Mantell, Patricia Dillard, Marie Davidian, Daowen Zhang, Warren J. Cantor, Michael H. Sketch,

Abstract

Currently recommended drug regimens to inhibit the platelet glycoprotein IIb/IIIa receptor have distinct pharmacodynamic profiles that might affect their relative efficacy in acute coronary syndromes and percutaneous coronary intervention.

References

	Year	Citations

Page 1